Please read and agree to the terms and conditions of this site.
@forbes.com 5 months ago
Buy, Sell, Or Hold MRNA Stock?
@qz.com a year ago
Moderna's new cancer vax, AstraZeneca CEO's big pay, and record-high drug shortages: Pharma news round up
@forbes.com a year ago
Moderna Stock Soars After Cancer Vaccine’s Strong Test Results
@qz.com 2 years ago
The end of zero-covid pushed China's biggest funeral services stock up by 80%
@theguardian.com 2 years ago
Nearly a fifth of Australia’s Covid vaccine stock binned amid warning of fresh wave of cases
@forbes.com 3 years ago
What To Expect From Walgreens Stock As It Reports Its Q2 Results?
@forbes.com 3 years ago
Novavax’s Revenues Will Surge This Year. Is The Stock A Buy?
@forbes.com 3 years ago
Flu Vaccine And Omicron Uncertainty Weighs On Moderna Stock. Time To Buy?
@rt.com 3 years ago
New Omicron variant could spell end for Covid-19 pandemic – top Russian scientist
@forbes.com 3 years ago
What Will We See From CVS Health Stock Post Q3 Results?
@forbes.com 3 years ago
Down 34% Last Month, Should You Buy BioNTech Stock For Near-Term Gains?
@forbes.com 4 years ago
Moderna’s R&D Day Indicates Covid-19 Will Remain The Biggest Driver Of The Stock
@fastcompany.com 7 months ago
Moderna stock plunges nearly 20% as company reports poor COVID-19 vaccine sales and cuts to research plans
@qz.com a year ago
New data on Moderna's cancer vaccine sends stock rising
@forbes.com a year ago
Pfizer Stock Sinks To 10-Year Low—Why Investors Have Soured On Covid-Era Giant
@abcnews.go.com 2 years ago
Merck, Moderna detail potential skin cancer vaccine progress
@forbes.com 3 years ago
Moderna - Not Your Hot-Tip-From-Your-Brother-In-Law Biotech Stock
@forbes.com 3 years ago
Moderna Stock Plunges Despite 'Vaccine Day' Touting 31 New Shots And $21 Billion In Sales—Here's Why
@forbes.com 3 years ago
What’s Happening With Novavax Stock?
@forbes.com 3 years ago
Does Omicron Help Or Hurt Novavax Stock?
@forbes.com 3 years ago
What’s Next For Novavax Stock After A Large 48% Rise In A Month?
@forbes.com 3 years ago
Is Pfizer Stock Set To See Higher Levels Post Q3 Results?
@forbes.com 3 years ago
What To Expect From Walgreens’ Stock As It Reports Q4 Results?
@forbes.com 4 years ago
After The Recent 4% Fall Will Pfizer Stock Rebound To Make Fresh Highs?
@qz.com 10 months ago
Promising trial data for Moderna's skin cancer vaccine sends stock rising
@qz.com a year ago
Even a new and improved COVID vaccine isn't budging Moderna stock
@forbes.com 2 years ago
Covid Vaccine Makers' Stocks Crash To Multiyear Lows Monday As Sales Keep Sliding
@forbes.com 2 years ago
Moderna Stock Futures: Is COVID Vaccine Maker Moderna Poised To Pop Or Drop?
@forbes.com 3 years ago
What’s Happening With Moderna Stock?
@forbes.com 3 years ago
Rising Covid Cases, Talk Of Second Booster Drive Moderna Stock Higher. Will The Rally Continue?
@forbes.com 3 years ago
Pfizer Triggers $28 Billion Stock Plunge After Warning Covid Vaccine Sales May Disappoint This Year
@forbes.com 3 years ago
With A Delayed Vaccine And New Virus Variants Emerging, Where Does Novavax Stock Stand?
@forbes.com 3 years ago
European Regulator Starts Assessing Novavax’s Covid Vaccine—Stock Jumps 8%
@forbes.com 3 years ago
Novavax Hasn’t Delivered A Vaccine Yet, But The Stock May Be Worth A Look
@forbes.com 4 years ago
Moderna Crash Wipes Out $22 Billion In Value After Merck's Covid Pill Triggers Vaccine Stock Plunge
@qz.com 4 years ago
India has approved the world’s first DNA vaccine for Covid-19 without any trial data
@qz.com a year ago
Novavax stock skyrockets 120% on $1.2 billion vaccine deal with Sanofi
@qz.com a year ago
Moderna is still turning a profit even though fewer people are using its only product
@forbes.com 2 years ago
Who Got Poorer This Week: The World’s Richest Person, An EV Battery Billionaire And Covid Vaccine Tycoons
@guardian 2 years ago Nearly a fifth of Australia’s Covid vaccine stock binned amid warning of fresh wave of cases theguardian.com
@forbes.com 3 years ago
Novavax Stock Halted Pending FDA Panel Meeting—Here’s What To Know About The Company’s Covid Vaccine
@forbes.com 3 years ago
Down 18% Over The Last Month, What’s Next For Novavax Stock?
@forbes.com 3 years ago
Novavax Files For U.S. Authorization. Is The Stock Finally A Buy?
@forbes.com 3 years ago
Is Moderna Stock A Good Bet Against The New Omicron Covid-19 Strain?
@forbes.com 3 years ago
Should You Buy Novavax Stock As It Wins Its First Regulatory Approval?
@forbes.com 3 years ago
Novavax Stock Plunges As Manufacturing Problems Reportedly Imperil The Firm's Covid-19 Vaccine
@forbes.com 4 years ago
What’s New With BioNTech Stock?
@qz.com 4 years ago
Moderna is buying back $1 billion of its stock after another bumper quarter